Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan

Liposomal amphotericin B (L-AMB) is a broad-spectrum antifungal drug that is used to treat fungal infections. However, clinical evidence of its use in patients with renal failure is limited. Here, we aimed to identify factors associated with acute kidney injury (AKI) in patients administered L-AMB....

Descripción completa

Detalles Bibliográficos
Autores principales: Takazono, Takahiro, Tashiro, Masato, Ota, Yuki, Obata, Yoko, Wakamura, Tomotaro, Miyazaki, Taiga, Nishino, Tomoya, Izumikawa, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490360/
https://www.ncbi.nlm.nih.gov/pubmed/32929112
http://dx.doi.org/10.1038/s41598-020-72135-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490360/
https://www.ncbi.nlm.nih.gov/pubmed/32929112
http://dx.doi.org/10.1038/s41598-020-72135-y

Ejemplares similares